Close
Achema middle east
swop processing & packaging

Bristol-Myers Squibb to Announce Results for First Quarter 2013 on April 25

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

UK Exchequer Wants More Pharma Investment Coming in Britain

Rachel Reeves, the UK Chancellor of the Exchequer, has...

Advanced Drug Delivery Platforms Enhancing Bioavailability

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry...

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry...

Bristol-Myers Squibb Company will announce results for the first quarter of 2013 on Thursday April 25 2013. During a conference call at 10:30 a.m. EDT on April 25 company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing 913-312-0650 confirmation code: 1234744. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 2 p.m. EDT on April 25 through midnight EDT on May 9 2013. The replay will also be available through http://investor.bms.com or by dialing 402-280-9013 confirmation code: 1234744.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover develop and deliver innovative medicines that help patients prevail over serious diseases.

 

 

Latest stories

Related stories

UK Exchequer Wants More Pharma Investment Coming in Britain

Rachel Reeves, the UK Chancellor of the Exchequer, has...

Advanced Drug Delivery Platforms Enhancing Bioavailability

Enhancing Bioavailability Through Advanced Drug Delivery Platforms The pharmaceutical industry...

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »